MAM
Vikram Sakhuja to chair EFFIE 2016; Mitrajit Bhattacharya will be co-chair
MUMBAI: The Advertising Club has appointed Madison World groyup CEO Vikram Sakhuja as president of EFFIES 2016. Chitralekha Group president and publisher Mitrajit Bhattacharya will be the co-chair of EFFIES 2016.
Speaking of Sakhuja’s appointment, The Advertising Club president Raj Nayak said, “EFFIES has emerged as a coveted industry award that lauds campaigns and individuals delivering landmark brand solutions. Vikram has been an essential part of EFFIES 2015 and was instrumental in ensuring the awards success last year. I am delighted that Vikram will be at the helm of the prestigious awards this year too. I am confident that under his leadership the awards will gain further in repute, stature and scale. Wishing all the best to Vikram and the team.”
Speaking about his new role Sakhuja said “It is a privilege to be chairing the EFFIES. It remains the one award that Agencies and client covet equally since it celebrates effectiveness. This year the EFFIES will be held in December, a little earlier than last year to ensure that Christmas and New Year is not spent working on entries. We look forward to again welcoming great work from all quarters.”
EFFIES 2016 will continue to celebrate successful campaigns that drive the Media and Advertising industry towards now echelons of growth and scale.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
